Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Quin-Dalf-Quinupristin-Dalfopristin, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
HUP Outpatients, Jan-Dec 2008, Blood Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Eryth	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	31	7	48	56	48	100	48	100	55	90	100	100	100
Coag negative staphylococci	21	0	14	62**	30	74	14	nt	62	67	100	100	100
Enterococcus sp	14	79	R+	nt	29	nt*	nt	R+	57	nt	100	14	86
**CNS not routinely tested for inducible clinidamycin resistance,  susceptibily may be higher
* high level gentamicin not available for technical reasons
+ R intrinsic resistance
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	24	38	58	71	88	92	92	96	100	71	63(88)	79	100
K. pneumoniae	21	0	100	95	100	100	100	100	100	100	10(100)	95	100
HUP Outpatients, Jan-Dec 2008, Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp of Pen	Amp/Sulb or Amox/Clav	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	1426	9	75	54	74	38	99	54	97	76	95	100	100	100
Coag negative staphylococci	13	0	29	29	57**	46	69	29	nt	21	80	100	100	100
Enterococcus sp	43	84	nt	R+	nt	24	nt	nt	R+	83	28	95	17	91
*CNS not tested for inducible clindamycin resistance, susceptibility may be higher
+ R intrinsic resistance
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero (Imip)	Pip (Pip/Tazo)	Tmp/Sxt
Pantoea (Enterobacter) aerogenes	12	0	0	0	100	100	100	100	100	100	100	100(100)	100
E. cloacae	52	0	0	0	100	100	100	10	100	100	100	89(100)	89
E. coli	95	44	57	91	98	98	86	86	100	62	100	65(98)	70
K. pneumoniae	53	0	82	91	94	93	96	93	96	91	94	0(91)	89
K. oxytoca	36	0	92	78	97	100	95	100	100	97	97	3(97)	92
P. mirabilis	75	100	100	97	100	100	100	100	100	97	100	100(100)	93
P. aeruginosa	404	R+	R+	R+	93	90	76	87	81	71	92	92	R+
Steno. maltophila	15	R+	R+	R+	R+	R+	R+	R+	R+	nt	R+	nt	80
S, marcescens	35	0	0	0	100	100	100	97	100	97	100	94(100)	100
+ R intrinsic resistance
HUP Outpatients, Jan-Dec 2008, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amox/Clav	Cefaz	Ery	Clinda	Gent	Naf	Nitro	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	124	7	60	55	33	48	98	60	98	96	64	81	100	100	100
Coag negative staphylococci	281	10	40	36	38	71**	90	41	100	nt	59	nt	99	99	100
Enterococcus sp	537	96	nt	R+	21	nt	nt	nt	96	R+	80	22	98	5	96
**CNS not routinely tested for inducible clindamycin resistance, susceptibility may be higher
+ R intrinsic resistance
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefp	Gent	Tobra	Amik	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
C. koseri	48	0	99	97	100	nt	100	100	nt	100	100	80	nt	100	99	nt
C. freundii	40	0	5	0	90	nt	95	98	nt	92	93	93	nt	83	85	nt
Pantoea (Enterobacter) aerogenes	67	0	2	0	99	nt	100	100	nt	100	100	10	nt	100	98	nt
E. cloacae	50	0	2	0	94	nt	92	94	nt	94	64	18	nt	88	82	nt
E. coli	3233	59	83	93	98	nt	94	94	nt	84	84	95	nt	80	79	nt
K. pneumoniae	510	0	93	92	94	nt	96	93	nt	92	92	29	nt	89	88	nt
K. oxytoca	27	0	85	70	100	nt	96	93	nt	96	96	70	nt	85	90	nt
M. morganii	20	0	0	5	95	nt	90	100	nt	75	75	0	nt	75	45	nt
P. mirabilis	237	96	99	99	99	nt	97	99	nt	91	92	0	nt	92	0	nt
P. aeruginosa	54	R+	R+	R+	98	94	91	96	96	77	nt	R+	92	R+	nt	93
+ R intrinsic resistance